Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2002

Conditions
Prostatic Neoplasms
Interventions
BIOLOGICAL

MVA-MUC1-IL2

Trial Locations (3)

44195

Cleveland Clinic Foundation, Cleveland

85724

Arizona Cancer Center, Tucson

90095

UCLA, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

University of Arizona

OTHER

lead

Transgene

INDUSTRY